Literature DB >> 11815373

Histamine H3-receptor-mediated [35S]GTP gamma[S] binding: evidence for constitutive activity of the recombinant and native rat and human H3 receptors.

A Rouleau1, X Ligneau, J Tardivel-Lacombe, S Morisset, F Gbahou, J-C Schwartz, J-M Arrang.   

Abstract

Constitutive activity of the recombinant and native rat and human H(3) receptors (H(3)Rs) was studied using H(3)R-mediated [(35)S]GTPgamma[S] binding and [(3)H]-arachidonic acid release. Ciproxifan, an inverse agonist at the rat H(3)R (rH(3)R), decreased [(3)H]arachidonic acid release from CHO cells expressing moderate densities (approximately 200 - 300 fmol mg(-1) protein) of the human H(3)R (hH(3)R). This effect occurred with the same magnitude than at the rH(3)R. The expression of the hH(3)R was associated with an increase in [(35)S]GTPgamma[S] binding to membranes of CHO cells. Ciproxifan decreased [(35)S]GTPgamma[S] binding to membranes of CHO (hH(3)R) cells. Both effects were correlated to receptor density and revealed that constitutive activity of the hH(3)R, although lower than that of the rH(3)R in this assay, was again observed at physiological densities (<500 fmol mg(-1) protein). Ciproxifan was less potent at the human than the rat receptor, not only as an antagonist (K(i)=45 nM), but also as an inverse agonist (EC(50)=15 nM). Constitutive activity of the hH(3)R was also evidenced using inhibition of [(35)S]GTPgamma[S] binding by unlabelled GTPgammaS. The expression of the hH(3)R generated a high affinity binding for GTPgammaS which was increased by imetit, but partially decreased by ciproxifan, therefore acting as a partial inverse agonist. [(35)S]GTPgamma[S] binding to rat brain membranes was decreased in several regions by thioperamide, ciproxifan and FUB 465, three inverse agonists at the H(3)R, whose effects were blocked by proxyfan, a neutral antagonist. [(35)S]GTPgamma[S] binding was also decreased by an A(1)-adenosine receptor inverse agonist, but remained unchanged in the presence of inverse agonists at D(2)/D(3) dopamine, H(1) and H(2) histamine, alpha(2)-adrenergic and delta opioid receptors. In conclusion, the present study shows that the recombinant rat and human H(3) receptors expressed at physiological densities display constitutive activity and suggests that constitutive activity of native H(3)Rs is one of the highest among G-protein-coupled receptors present in rat brain.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11815373      PMCID: PMC1573152          DOI: 10.1038/sj.bjp.0704490

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  55 in total

1.  Agonist and inverse agonist efficacy at human recombinant serotonin 5-HT1A receptors as a function of receptor:G-protein stoichiometry.

Authors:  A Newman-Tancredi; C Conte; C Chaput; L Verrièle; M J Millan
Journal:  Neuropharmacology       Date:  1997 Apr-May       Impact factor: 5.250

2.  Inverse agonism of histamine H2 antagonist accounts for upregulation of spontaneously active histamine H2 receptors.

Authors:  M J Smit; R Leurs; A E Alewijnse; J Blauw; G P Van Nieuw Amerongen; Y Van De Vrede; E Roovers; H Timmerman
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

3.  Sensitivity of histamine H3 receptor agonist-stimulated [35S]GTP gamma[S] binding to pertussis toxin.

Authors:  E A Clark; S J Hill
Journal:  Eur J Pharmacol       Date:  1996-01-25       Impact factor: 4.432

4.  The cubic ternary complex receptor-occupancy model. III. resurrecting efficacy.

Authors:  J M Weiss; P H Morgan; M W Lutz; T P Kenakin
Journal:  J Theor Biol       Date:  1996-08-21       Impact factor: 2.691

5.  Antipsychotics with inverse agonist activity at the dopamine D3 receptor.

Authors:  N Griffon; C Pilon; F Sautel; J C Schwartz; P Sokoloff
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

Review 6.  International Union of Pharmacology. XIII. Classification of histamine receptors.

Authors:  S J Hill; C R Ganellin; H Timmerman; J C Schwartz; N P Shankley; J M Young; W Schunack; R Levi; H L Haas
Journal:  Pharmacol Rev       Date:  1997-09       Impact factor: 25.468

7.  Structure/function relationships of calcitonin analogues as agonists, antagonists, or inverse agonists in a constitutively activated receptor cell system.

Authors:  G Pozvek; J M Hilton; M Quiza; S Houssami; P M Sexton
Journal:  Mol Pharmacol       Date:  1997-04       Impact factor: 4.436

Review 8.  The physiology of brain histamine.

Authors:  R E Brown; D R Stevens; H L Haas
Journal:  Prog Neurobiol       Date:  2001-04       Impact factor: 11.685

9.  [125I]iodoproxyfan, a new antagonist to label and visualize cerebral histamine H3 receptors.

Authors:  X Ligneau; M Garbarg; M L Vizuete; J Diaz; K Purand; H Stark; W Schunack; J C Schwartz
Journal:  J Pharmacol Exp Ther       Date:  1994-10       Impact factor: 4.030

10.  Constitutive activation of a single effector pathway: evidence for multiple activation states of a G protein-coupled receptor.

Authors:  D M Perez; J Hwa; R Gaivin; M Mathur; F Brown; R M Graham
Journal:  Mol Pharmacol       Date:  1996-01       Impact factor: 4.436

View more
  22 in total

1.  Protean agonism at histamine H3 receptors in vitro and in vivo.

Authors:  Florence Gbahou; Agnès Rouleau; Séverine Morisset; Régis Parmentier; Sylvain Crochet; Jian-Sheng Lin; Xavier Ligneau; Joël Tardivel-Lacombe; Holger Stark; Walter Schunack; C Robin Ganellin; Jean-Charles Schwartz; Jean-Michel Arrang
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-05       Impact factor: 11.205

Review 2.  Central nervous system biogenic amine targets for control of appetite and energy expenditure.

Authors:  David L Nelson; Donald R Gehlert
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

3.  Compared pharmacology of human histamine H3 and H4 receptors: structure-activity relationships of histamine derivatives.

Authors:  Florence Gbahou; Ludwig Vincent; Marie Humbert-Claude; Joel Tardivel-Lacombe; Claude Chabret; Jean-Michel Arrang
Journal:  Br J Pharmacol       Date:  2006-04       Impact factor: 8.739

4.  H3 receptor antagonists reverse delay-dependent deficits in novel object discrimination by enhancing retrieval.

Authors:  Vincent Pascoli; Corinne Boer-Saccomani; Jean-François Hermant
Journal:  Psychopharmacology (Berl)       Date:  2008-05-22       Impact factor: 4.530

5.  h5-HT(1B) receptor-mediated constitutive Galphai3-protein activation in stably transfected Chinese hamster ovary cells: an antibody capture assay reveals protean efficacy of 5-HT.

Authors:  Adrian Newman-Tancredi; Didier Cussac; Laetitia Marini; Manuelle Touzard; Mark J Millan
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

6.  Samelisant (SUVN-G3031), a potent, selective and orally active histamine H3 receptor inverse agonist for the potential treatment of narcolepsy: pharmacological and neurochemical characterisation.

Authors:  Ramakrishna Nirogi; Vijay Benade; Saivishal Daripelli; Ramkumar Subramanian; Venkatesh Kamuju; Gopinadh Bhyrapuneni; Nageswara Rao Muddana; Venkat Reddy Mekala; Surendra Petlu; Pradeep Jayarajan; Rajesh Badange; Anil Shinde; Venkat Jasti
Journal:  Psychopharmacology (Berl)       Date:  2021-02-07       Impact factor: 4.530

Review 7.  Histamine in the regulation of wakefulness.

Authors:  Mahesh M Thakkar
Journal:  Sleep Med Rev       Date:  2010-09-20       Impact factor: 11.609

8.  Ciproxifan, a histamine H3-receptor antagonist/inverse agonist, potentiates neurochemical and behavioral effects of haloperidol in the rat.

Authors:  Catherine Pillot; Jordi Ortiz; Anne Héron; Sophie Ridray; Jean-Charles Schwartz; Jean-Michel Arrang
Journal:  J Neurosci       Date:  2002-08-15       Impact factor: 6.167

9.  A single-point mutation (Ala280Val) in the third intracellular loop alters the signalling properties of the human histamine H₃ receptor stably expressed in CHO-K1 cells.

Authors:  Cecilia Flores-Clemente; Angélica Osorio-Espinoza; Juan Escamilla-Sánchez; Rob Leurs; Juan-Manuel Arias; José-Antonio Arias-Montaño
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

10.  Influence of the novel histamine H₃ receptor antagonist ST1283 on voluntary alcohol consumption and ethanol-induced place preference in mice.

Authors:  Amine Bahi; Bassem Sadek; Stephan J Schwed; Miriam Walter; Holger Stark
Journal:  Psychopharmacology (Berl)       Date:  2013-03-09       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.